PositiveID gets FDA clearance for iglucose technology

11/16/2011 | Health Data Management

The FDA has given PositiveID Corp. 510(k) clearance for its iglucose technology designed for patients with diabetes. The device enables patients to transmit blood glucose readings from a data-cable glucometer to a Web portal, where they can transmit information to family members and health care providers.

View Full Article in:

Health Data Management

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD